PulseAugur
EN
LIVE 10:35:11
中文(ZH) 同和药业:两款药品获得澳大利亚药品GMP符合性证书

Tonghe Pharma gets Australian drug certs; Huayuan Holdings secures loan; DeepSeek ranks first in calls

Tonghe Pharmaceutical has received Australian GMP compliance certificates for two of its drugs, Mirabegron and Empagliflozin. Separately, Huayuan Holdings announced a loan commitment of up to 90 million yuan from the Industrial and Commercial Bank of China for stock buybacks. The digest also mentions that Fuliang, the half-brother of Zong Fuli, has been appointed chairman of a new company, DeepSeek has reached the top global ranking for call volume, and iPhones may see a price increase of over a thousand yuan. AI

IMPACT DeepSeek's rise in global call volume may indicate increased adoption and usage of its AI models.

RANK_REASON The item is a news digest covering multiple unrelated topics, none of which are a primary source for a frontier release, significant event, or research.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Tonghe Pharma gets Australian drug certs; Huayuan Holdings secures loan; DeepSeek ranks first in calls

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Tonghe Pharmaceutical: Two Drugs Obtain Australian Drug GMP Compliance Certificate

    36氪获悉,同和药业公告,公司于近日收到澳大利亚药品管理局颁发的米拉贝隆、恩格列净药品GMP符合性证书。